Maintenance Peginterferon Therapy and Other Factors Associated With Hepatocellular Carcinoma in Patients With Advanced Hepatitis C
- 1 March 2011
- journal article
- research article
- Published by Elsevier in Gastroenterology
- Vol. 140 (3), 840-849.e1
- https://doi.org/10.1053/j.gastro.2010.11.050
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Outcome of Sustained Virological Responders With Histologically Advanced Chronic Hepatitis C†,‡,§,¶Hepatology, 2010
- Interaction between Cigarette Smoking and Hepatitis B and C Virus Infection on the Risk of Liver Cancer: A Meta-analysisCancer Epidemiology, Biomarkers & Prevention, 2010
- Clearing the Smoke in Chronic Liver DiseasesHepatology, 2010
- Systematic review: the association between obesity and hepatocellular carcinoma – epidemiological evidenceAlimentary Pharmacology & Therapeutics, 2010
- Interferon-α as angiogenesis inhibitor: Learning from tumor modelsAutoimmunity, 2010
- Prolonged Therapy of Advanced Chronic Hepatitis C with Low-Dose PeginterferonNew England Journal of Medicine, 2008
- Prevalence and Prognostic Significance of the Presence of Esophageal Varices in Patients With Hepatocellular CarcinomaClinical Gastroenterology and Hepatology, 2006
- Alcohol, tobacco and obesity are synergistic risk factors for hepatocellular carcinomaJournal of Hepatology, 2004
- Long-term high-dose interferon-α therapy delays Hepadnavirus-related hepatocarcinogenesis in X/myc transgenic miceOncogene, 2003
- Histological grading and staging of chronic hepatitisJournal of Hepatology, 1995